Literature DB >> 29786549

Pluripotent stem cells: induction and self-renewal.

R Abu-Dawud1, N Graffmann2, S Ferber2, W Wruck2, J Adjaye3.   

Abstract

Pluripotent stem cells (PSCs) lie at the heart of modern regenerative medicine due to their properties of unlimited self-renewal in vitro and their ability to differentiate into cell types representative of the three embryonic germ layers-mesoderm, ectoderm and endoderm. The derivation of induced PSCs bypasses ethical concerns associated with the use of human embryonic stem cells and also enables personalized cell-based therapies. To exploit their regenerative potential, it is essential to have a firm understanding of the molecular processes associated with their induction from somatic cells. This understanding serves two purposes: first, to enable efficient, reliable and cost-effective production of excellent quality induced PSCs and, second, to enable the derivation of safe, good manufacturing practice-grade transplantable donor cells. Here, we review the reprogramming process of somatic cells into induced PSCs and associated mechanisms with emphasis on self-renewal, epigenetic control, mitochondrial bioenergetics, sub-states of pluripotency, naive ground state, naive and primed. A meta-analysis identified genes expressed exclusively in the inner cell mass and in the naive but not in the primed pluripotent state. We propose these as additional biomarkers defining naive PSCs.This article is part of the theme issue 'Designer human tissue: coming to a lab near you'.
© 2018 The Author(s).

Entities:  

Keywords:  epigenetics; iPSC; naive; pluripotency; primed; urine

Mesh:

Year:  2018        PMID: 29786549      PMCID: PMC5974437          DOI: 10.1098/rstb.2017.0213

Source DB:  PubMed          Journal:  Philos Trans R Soc Lond B Biol Sci        ISSN: 0962-8436            Impact factor:   6.237


  142 in total

1.  Embryonic germ cells induce epigenetic reprogramming of somatic nucleus in hybrid cells.

Authors:  M Tada; T Tada; L Lefebvre; S C Barton; M A Surani
Journal:  EMBO J       Date:  1997-11-03       Impact factor: 11.598

2.  Actin-myosin contractility is responsible for the reduced viability of dissociated human embryonic stem cells.

Authors:  Guokai Chen; Zhonggang Hou; Daniel R Gulbranson; James A Thomson
Journal:  Cell Stem Cell       Date:  2010-08-06       Impact factor: 24.633

3.  Derivation and characterization of integration-free iPSC line ISRM-UM51 derived from SIX2-positive renal cells isolated from urine of an African male expressing the CYP2D6 *4/*17 variant which confers intermediate drug metabolizing activity.

Authors:  Martina Bohndorf; Audrey Ncube; Lucas-Sebastian Spitzhorn; Jürgen Enczmann; Wasco Wruck; James Adjaye
Journal:  Stem Cell Res       Date:  2017-10-07       Impact factor: 2.020

4.  Stage-specific optimization of activin/nodal and BMP signaling promotes cardiac differentiation of mouse and human pluripotent stem cell lines.

Authors:  Steven J Kattman; Alec D Witty; Mark Gagliardi; Nicole C Dubois; Maryam Niapour; Akitsu Hotta; James Ellis; Gordon Keller
Journal:  Cell Stem Cell       Date:  2011-02-04       Impact factor: 24.633

5.  Pan-Src family kinase inhibitors replace Sox2 during the direct reprogramming of somatic cells.

Authors:  Judith Staerk; Costas A Lyssiotis; Lea A Medeiro; Michael Bollong; Ruth K Foreman; Shoutian Zhu; Michael Garcia; Qing Gao; Laure C Bouchez; Luke L Lairson; Bradley D Charette; Lubica Supekova; Jeffrey Janes; Achim Brinker; Charles Y Cho; Rudolf Jaenisch; Peter G Schultz
Journal:  Angew Chem Int Ed Engl       Date:  2011-05-05       Impact factor: 15.336

6.  Highly efficient miRNA-mediated reprogramming of mouse and human somatic cells to pluripotency.

Authors:  Frederick Anokye-Danso; Chinmay M Trivedi; Denise Juhr; Mudit Gupta; Zheng Cui; Ying Tian; Yuzhen Zhang; Wenli Yang; Peter J Gruber; Jonathan A Epstein; Edward E Morrisey
Journal:  Cell Stem Cell       Date:  2011-04-08       Impact factor: 24.633

7.  Induced pluripotent stem cells generated without viral integration.

Authors:  Matthias Stadtfeld; Masaki Nagaya; Jochen Utikal; Gordon Weir; Konrad Hochedlinger
Journal:  Science       Date:  2008-09-25       Impact factor: 47.728

8.  Replacing reprogramming factors with antibodies selected from combinatorial antibody libraries.

Authors:  Joel W Blanchard; Jia Xie; Nadja El-Mecharrafie; Simon Gross; Sohyon Lee; Richard A Lerner; Kristin K Baldwin
Journal:  Nat Biotechnol       Date:  2017-09-11       Impact factor: 54.908

9.  Derivation of naive human embryonic stem cells.

Authors:  Carol B Ware; Angelique M Nelson; Brigham Mecham; Jennifer Hesson; Wenyu Zhou; Erica C Jonlin; Antonio J Jimenez-Caliani; Xinxian Deng; Christopher Cavanaugh; Savannah Cook; Paul J Tesar; Jeffrey Okada; Lilyana Margaretha; Henrik Sperber; Michael Choi; C Anthony Blau; Piper M Treuting; R David Hawkins; Vincenzo Cirulli; Hannele Ruohola-Baker
Journal:  Proc Natl Acad Sci U S A       Date:  2014-03-12       Impact factor: 11.205

10.  Highly efficient direct conversion of human fibroblasts to neuronal cells by chemical compounds.

Authors:  Ping Dai; Yoshinori Harada; Tetsuro Takamatsu
Journal:  J Clin Biochem Nutr       Date:  2015-04-01       Impact factor: 3.114

View more
  9 in total

1.  Generating iPSCs with a High-Efficient, Non-Invasive Method-An Improved Way to Cultivate Keratinocytes from Plucked Hair for Reprogramming.

Authors:  Lisa S Wüstner; Moritz Klingenstein; Karl G Frey; Mohammad R Nikbin; Alfio Milazzo; Alexander Kleger; Stefan Liebau; Stefanie Klingenstein
Journal:  Cells       Date:  2022-06-17       Impact factor: 7.666

2.  Physoxia Influences Global and Gene-Specific Methylation in Pluripotent Stem Cells.

Authors:  Fatma Dogan; Rakad M Kh Aljumaily; Mark Kitchen; Nicholas R Forsyth
Journal:  Int J Mol Sci       Date:  2022-05-23       Impact factor: 6.208

3.  Designer human tissue: coming to a lab near you.

Authors:  David C Hay; Cliona O'Farrelly
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2018-07-05       Impact factor: 6.237

Review 4.  Induced Pluripotency: A Powerful Tool for In Vitro Modeling.

Authors:  Romana Zahumenska; Vladimir Nosal; Marek Smolar; Terezia Okajcekova; Henrieta Skovierova; Jan Strnadel; Erika Halasova
Journal:  Int J Mol Sci       Date:  2020-11-24       Impact factor: 5.923

5.  WDR36 Safeguards Self-Renewal and Pluripotency of Human Extended Pluripotent Stem Cells.

Authors:  Shiyu An; Dan Yao; Wenyi Zhang; Hao Sun; Tianyi Yu; Ruizhe Jia; Yang Yang
Journal:  Front Genet       Date:  2022-07-22       Impact factor: 4.772

Review 6.  Bilirubin-Induced Neurological Damage: Current and Emerging iPSC-Derived Brain Organoid Models.

Authors:  Abida Islam Pranty; Sara Shumka; James Adjaye
Journal:  Cells       Date:  2022-08-25       Impact factor: 7.666

7.  A Comparative Study of Cell Culture Conditions during Conversion from Primed to Naive Human Pluripotent Stem Cells.

Authors:  Irene Romayor; Lara Herrera; Maria Burón; Myriam Martin-Inaraja; Laura Prieto; Jone Etxaniz; Marta Inglés-Ferrándiz; Jose Ramon Pineda; Cristina Eguizabal
Journal:  Biomedicines       Date:  2022-06-09

8.  Age-Associated Loss in Renal Nestin-Positive Progenitor Cells.

Authors:  Marina I Buyan; Nadezda V Andrianova; Vasily A Popkov; Ljubava D Zorova; Irina B Pevzner; Denis N Silachev; Dmitry B Zorov; Egor Y Plotnikov
Journal:  Int J Mol Sci       Date:  2022-09-20       Impact factor: 6.208

9.  Global trends in clinical trials involving pluripotent stem cells: a systematic multi-database analysis.

Authors:  Julia Deinsberger; David Reisinger; Benedikt Weber
Journal:  NPJ Regen Med       Date:  2020-09-11
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.